[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Group for Research in Adult Acute Lymphoblastic Leukemia\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":42},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":5},"100626266","long-term-progression-of-patients-treated-and-monitored-for-relapsed-or-refractory-ph-all-100626266",false,"NCT07433400","Long-term Progression of Patients Treated and Monitored for Relapsed or Refractory Ph+ ALL","Retrospective Study of the Long-term Progression of Patients Treated and Monitored for Relapsed or Refractory Ph+ ALL","EVOLALPh1","Inclusion Criteria:\n\n* Age \\>= 18\n* Relapse or refractory Ph1 ALL\n\nExclusion Criteria:\n\n* none","ALL","18 Years",{"count":20,"type":21},500,"ESTIMATED","15 Years","OBSERVATIONAL","The objective of this retrospective study is to examine the outcome of patients who relapse with Ph+ ALL and to potentially identify response profiles in order toadvance the treatment regimens that can be offered.",[26],"Ph Positive ALL",[28,29],"1ST RELAPSE OR MORE","TKI","RECRUITING","2026-02-24",{"date":33,"type":34},"2026-02-25","ACTUAL",{"date":36,"type":34},"2025-08-29",{"date":38,"type":21},"2035-12-31",{"name":40,"class":41},"Group for Research in Adult Acute Lymphoblastic Leukemia","OTHER",""]